Nexterone recalls
Nexterone products have been recalled 2 times, most recently on 9 Sep 2026. The recalling company is usually Baxter Healthcare. The most common reason is sterility.
Total recalls2since 2018
Last 12 months1reported
Class I150% of total
Ongoing1latest 9 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 50%Class II 1 50%Class III 0 0%
Why nexterone is recalled
Companies
Product types
By year
Ongoing nexterone recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nexterone (amiodarone HCI), 360 mg/ 8 mg/mL) recalledNexterone | Baxter Healthcare | Sterility | Nationwide |
All nexterone recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nexterone (amiodarone HCI), 360 mg/ 8 mg/mL) recalledNexterone | Baxter Healthcare | Sterility | Nationwide |
| Drug | CLASS I | Nexterone (amiodarone HCl) Premixed Injection, 150mg recalledNexterone | Baxter Healthcare | Particulate Matter | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.